Documents & Downloads

Canvircept

ACE2 Fusion Protein

Canvircept is a recombinant fusion protein that combines angiotensin-converting enzyme 2 (ACE2) with a human IgG1 Fc fragment. This construct is engineered to effectively bind to the spike protein of SARS-CoV-2, thereby inhibiting viral entry into host cells. Canvircept serves as a valuable tool for studying the interactions between ACE2 and viral components, as well as for potential therapeutic applications in COVID-19 research.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2833647-10-0
Applications	ACE2 Fusion Protein

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.